Liquid Pediatric Market size is anticipated to reach USD 20 billion by the end of 2036, growing at a CAGR of 8% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of liquid pediatrics was over USD 10 billion.
The burgeoning demand for child-friendly medications, particularly in liquid form, stands as a pivotal growth driver for the market. This surge is propelled by a fundamental need to enhance medication adherence and ease administration for children who may struggle with swallowing conventional pills or tablets.
Pharmaceutical companies are increasingly recognizing the significance of developing formulations that are not only efficacious but also palatable and easily consumable for the pediatric demographic.
According to a survey, 78% of parents reported that their children refuse to take medication. Liquid medications offer a practical solution to the challenges associated with administering drugs to children. The palatable nature of liquid formulations makes them more appealing to children, significantly improving medication adherence.
Liquid pediatric refers to medications or medical products specifically formulated for pediatric use and administered in liquid form. This is often done to make it easier for children to take the medication, as they may have difficulty swallowing pills or tablets. Liquid formulations are also advantageous for accurate dosing in children, as doses can be adjusted more precisely based on the child's weight.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
8% |
|
Base Year Market Size (2023) |
USD 10 Billion |
|
Forecast Year Market Size (2036) |
USD 20 Billion |
|
Regional Scope |
|
Type (Oral Solution, Emulsion)
In liquid pediatric market, emulsion segment is poised to capture around 60% share by the end of 2036. regulatory environment, with an emphasis on supporting pediatric drug development, acts as a growth driver for the emulsions segment.
Regulatory bodies recognize the unique challenges in pediatric formulations and encourage innovation to meet the specific needs of children. Emulsions, with their formulation flexibility, align with regulatory goals for enhancing pediatric medication options.
Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have implemented measures to incentivize pediatric drug development. These initiatives acknowledge the importance of diverse formulations, such as emulsions, in providing safe and effective treatment options for pediatric patients.
Increased preference for palatable formulations, enhanced bioavailability, and regulatory support for pediatric drug development are the growth driving factors for the emulsion segment of the liquid pediatric market.
End User (Hospitals, Clinics, Homecare)
The hospital segment in liquid pediatric market is expected to garner a significant share in the year 2036. Hospital formulary decisions play a pivotal role in shaping the medication landscape within healthcare institutions. The preferences of hospital formularies for liquid pediatric medications are driven by considerations such as ease of administration, patient compliance, and the ability to customize dosages for individual pediatric patients.
Many hospital pharmacies prefer liquid formulations for pediatric patients. This preference reflects the emphasis on formulations that align with pediatric dosing requirements and contribute to effective and safe medication administration in a hospital setting. The growth of the hospital segment in the liquid pediatric market is further propelled by factors such as the rising rate of pediatric admissions, the establishment of specialized pediatric units, the prevalence of respiratory conditions, enhanced medication adherence in inpatient settings, and hospital formulary preferences for liquid pediatric medications.
Our in-depth analysis of the global market includes the following segments:
|
Type |
|
|
End User |
|
Asia Pacific Market Forecast
By the end of 2036, Asia Pacific region is expected to capture around 39% liquid pediatric market share. The growing awareness among parents regarding the importance of pediatric healthcare and medication adherence is a significant driver for the market. Parents actively seek child-friendly formulations, such as liquid medications, for their ease of administration and improved palatability, contributing to better medication adherence in children.
According to a survey by the National Center for Biotechnology Information, 88.9% of liquid medications were used by caregivers who were young and educated women. The survey emphasized the impact of parental awareness on medication choices, highlighting the importance of catering to parental preferences in the market.
North American Market Statistics
The liquid pediatric market in the North American region is projected to hold a remarkable share over the forecast period. The market in the region is growing due to the increasing prevalence of pediatric chronic conditions.
Chronic diseases, such as asthma and diabetes, are rising among children, which require sustained and precise medications. According to the Asthma and Allergy Foundation of America, 4.5 million children in the United States have asthma. This underscores the substantial burden of chronic conditions among the pediatric population in North America, driving the demand for liquid pediatric medications.
Advancements in drug delivery systems specific to pediatric patients contribute significantly to the growth of the liquid pediatric market. Innovations in taste-masking technologies, improved stability of liquid formulations, and user-friendly packaging enhance the overall patient experience. These technological enhancements address the challenges associated with pediatric medication administration, fostering market expansion.
Author Credits: Radhika Gupta, Shivam Bhutani
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?